Skip to Content

Press Releases

Press Releases

Placing and Issue of Equity
Dec 15, 2017
Placing and Issue of Equity
Dec 15, 2017
Milciclib Phase 2a Trial Update
Dec 08, 2017
Phase II Clinical Trial Update
Nov 23, 2017
Interim Results for Six Months Ended 30 June 2017
Sep 29, 2017
Grant of options - Director's dealing
Aug 31, 2017
Publication of Research Article on Foralumab
Jul 28, 2017
Appointment of Dr Kunwar Shailubhai as CEO
Jun 12, 2017
NOTIFICATION OF MAJOR INTEREST IN SHARES
Jun 08, 2017
Displaying 411 - 420 of 468